- Filed
- Sep 2, 2025 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Mar 28, 2025 | 102.27M sh |
| Shares Diluted | Q3 2025 · Feb 28, 2025 | 101.99M sh |
| Shares Diluted | Q3 2025 · Feb 28, 2025 | 101.99M sh |
| Shares Diluted | Q3 2025 · Feb 29, 2024 | 101.71M sh |
| Shares Diluted | Q3 2025 · Feb 29, 2024 | 101.71M sh |
| Operating Cash Flow restated | Q3 2025 · Feb 28, 2025 | −$370.93K |
| Operating Cash Flow restated | Q3 2025 · Feb 29, 2024 | −$637.76K |
| Short Term Debt | Q3 2025 · Feb 28, 2025 | $25.49K |
| Cash And Equivalents | Q3 2025 · Feb 28, 2025 | $2.36K |
| Cash And Equivalents | Q3 2025 · May 31, 2024 | $2.52K |
| Stockholders Equity | Q3 2025 · Feb 28, 2025 | $489.77K |
| Stockholders Equity | Q3 2025 · May 31, 2024 | $364.54K |
| Current Liabilities | Q3 2025 · Feb 28, 2025 | $1.83M |
| Current Liabilities | Q3 2025 · May 31, 2024 | $1.98M |
| Total Liabilities | Q3 2025 · Feb 28, 2025 | $1.83M |
| Total Liabilities | Q3 2025 · May 31, 2024 | $1.99M |
| Current Assets | Q3 2025 · Feb 28, 2025 | $545.34K |
| Current Assets | Q3 2025 · May 31, 2024 | $535.3K |
| Total Assets | Q3 2025 · Feb 28, 2025 | $2.32M |
| Total Assets | Q3 2025 · May 31, 2024 | $2.36M |
| Eps Diluted | Q3 2025 · Feb 28, 2025 | $0.00 |
| Eps Diluted | Q3 2025 · Feb 28, 2025 | $0.00 |
| Eps Diluted | Q3 2025 · Feb 29, 2024 | $0.00 |
| Eps Diluted | Q3 2025 · Feb 29, 2024 | $0.00 |
| Eps Basic | Q3 2025 · Feb 28, 2025 | $0.00 |
| Eps Basic | Q3 2025 · Feb 28, 2025 | $0.00 |
| Eps Basic | Q3 2025 · Feb 29, 2024 | $0.00 |
| Eps Basic | Q3 2025 · Feb 29, 2024 | $0.00 |
| Sga Expense | Q3 2025 · Feb 28, 2025 | $79.98K |
| Sga Expense | Q3 2025 · Feb 28, 2025 | $286.1K |
| Sga Expense | Q3 2025 · Feb 29, 2024 | $132.96K |
| Sga Expense | Q3 2025 · Feb 29, 2024 | $917.61K |
| Net Income | Q3 2025 · Feb 28, 2025 | −$64.64K |
| Net Income | Q3 2025 · Feb 28, 2025 | −$249.9K |
| Net Income | Q3 2025 · Feb 29, 2024 | $108.74K |
| Net Income | Q3 2025 · Feb 29, 2024 | −$190.99K |
| Operating Income restated | Q3 2025 · Feb 28, 2025 | −$64.64K |
| Operating Income restated | Q3 2025 · Feb 28, 2025 | −$215.15K |
| Operating Income | Q3 2025 · Feb 29, 2024 | $113.9K |
| Operating Income | Q3 2025 · Feb 29, 2024 | −$189.39K |
| Gross Profit | Q3 2025 · Feb 28, 2025 | $62.1K |
| Gross Profit | Q3 2025 · Feb 28, 2025 | $222.55K |
| Gross Profit | Q3 2025 · Feb 29, 2024 | $326.74K |
| Gross Profit | Q3 2025 · Feb 29, 2024 | $1.14M |
| Cost Of Revenue | Q3 2025 · Feb 28, 2025 | $2.44K |
| Cost Of Revenue | Q3 2025 · Feb 28, 2025 | $57.25K |
| Cost Of Revenue | Q3 2025 · Feb 29, 2024 | $63.53K |
| Cost Of Revenue | Q3 2025 · Feb 29, 2024 | $623.43K |
| Revenue | Q3 2025 · Feb 28, 2025 | $64.54K |
| Revenue | Q3 2025 · Feb 28, 2025 | $279.8K |
| Revenue | Q3 2025 · Feb 29, 2024 | $390.27K |
| Revenue | Q3 2025 · Feb 29, 2024 | $1.76M |
| Capex | Q3 2025 · Feb 29, 2024 | $2.32K |